U.S. federal trademark · Serial No. 74570111 · Reg. No. 2207723
pharmaceutical preparations, namely anti-angiogenic protein compositions for the treatment of diseases and biological processes that are mediated by angiogenesis, namely cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.